Client News

Atriva Therapeutics appoints Christian Pangratz as Chief Executive Officer, implementing planned management change

InflaRx Reports Third Quarter 2022 Financial & Operating Results

ONWARD Reports Third Quarter 2022 Highlights and Provides Business Update

ONWARD Schedules Webcast to Provide Third Quarter Business Update and Announces Participation at Upcoming Conferences

avateramedical to present at ERUS meeting after successful completion of first live surgery at DRUS congress

AiCuris’ Licensing Partner MSD Demonstrates Efficacy in Phase 3 Study with PREVYMIS® for Prevention of Cytomegalovirus Disease in Adults After Kidney Transplantation

Atriva Therapeutics to take part in upcoming industry and investor conferences

Marinomed: First successful year on the market for Marinomed’s Solv4U technology partnerships

Apogenix’ Asunercept Demonstrates Efficacy in Phase II Trial for the Treatment of Hospitalized COVID-19 Patients

Spexis to present at BIO-Europe® 2022